Vaccine-induced CD8 T cells are redirected with peptide-MHC class I-IgG antibody fusion proteins to eliminate tumor cells in vivo-Reference-Cited by-同舟云学术

Vaccine-induced CD8 T cells are redirected with peptide-MHC class I-IgG antibody fusion proteins to eliminate tumor cells in vivo

Published:2020-01-01 Issue:1 Volume:12 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Fischer Cornelia¹,Munks Michael W.²,Hill Ann B.²,Kroczek Richard A.³,Bissinger Stefan⁴,Brand Verena⁴,Schmittnaegel Martina⁴,Imhof-Jung Sabine¹^ORCID,Hoffmann Eike¹,Herting Frank⁴,Klein Christian⁵^ORCID,Knoetgen Hendrik⁶

Affiliation:

1. Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany

2. Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA

3. Molecular Immunology, Robert-Koch-Institute, Berlin, Germany

4. Discovery Oncology, Roche Innovation Center Munich, Penzberg, Germany

5. Discovery Oncology, Roche Innovation Center Zurich, Zurich, Switzerland

6. Therapeutic Modalities, Roche Innovation Center Basel, Basel, Switzerland

Funder

Roche Diagnostics GmbH, Roche Glycart AG, or F. Hoffmann-La Roche Ltd

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2020.1834818

Reference33 articles.

1. CARs on a highway with roadblocks

2. Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

3. CEA TCB: A novel head-to-tail 2:1 T cell bispecific antibody for treatment of CEA-positive solid tumors

4. Cancer immunotherapy beyond immune checkpoint inhibitors

5. Active Antiviral T-Lymphocyte Response Can Be Redirected against Tumor Cells by Antitumor Antibody × MHC/Viral Peptide Conjugates

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release;mAbs;2024-08-28

2. Redirector of Vaccine-induced Effector Responses (RoVER) for specific killing of cellular targets;eBioMedicine;2023-10

3. Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)Therapy;Cancers;2023-07-25

4. Nanovaccine Displaying Immunodominant T Cell Epitopes of Fibroblast Activation Protein Is Effective Against Desmoplastic Tumors;ACS Nano;2023-05-15

5. Human leukocyte antigen and tumor immunotherapy (Review);International Journal of Oncology;2023-04-26